These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6401093)

  • 1. [A possible way of improving colibacterin].
    Shatilo VA; Bondarenko VM
    Mikrobiol Zh (1978); 1984; 46(1):61-6. PubMed ID: 6401093
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro model for the analysis of the interaction between Shigella flexneri and the intestinal epithelium].
    Raygoza-Anaya M; González-Robles A; Mora-Galindo J
    Arch Invest Med (Mex); 1990; 21(4):305-9. PubMed ID: 1669218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Allergy and intestinal flora].
    Matsumura T
    Nihon Ishikai Zasshi; 1971 Nov; 66(10):1086-98. PubMed ID: 4401255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of the cytotoxicity of shigellae in the infectious process].
    Dragunskaia EM; Bondarenko VM; Ravdonikas LE; Grabovskaia KB
    Vestn Akad Med Nauk SSSR; 1976; (1):21-4. PubMed ID: 790818
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct demonstration in intestinal secretions of an IgA memory response to orally administered Shigella flexneri antigens.
    Keren DF; Kern SE; Bauer DH; Scott PJ; Porter P
    J Immunol; 1982 Jan; 128(1):475-9. PubMed ID: 7033378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytotoxic factor of Flexner shigella, its biologic function and genetic control].
    Bondarenko VM
    Vestn Akad Med Nauk SSSR; 1976; (1):14-21. PubMed ID: 790817
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity of living attenuated shigellae.
    Serény B; Tenner C; Rácz P
    Acta Microbiol Acad Sci Hung; 1971; 18(4):239-45. PubMed ID: 4950775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the significance for immunogenicity of Sh. flexneri 2A type-specific antigen when using hybrids of definite genetic classes].
    Blinova NI; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):32-7. PubMed ID: 4133770
    [No Abstract]   [Full Text] [Related]  

  • 11. [Growth and development of a population of the causative agent during an infection].
    Pokrovskiĭ VI; Bondarenko VM; Zhalko-Titarenko VP
    Sov Med; 1987; (4):29-36. PubMed ID: 3299739
    [No Abstract]   [Full Text] [Related]  

  • 12. Salicin-fermenting variant of Shigella flexneri serotype 2a.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1965; 12(1):7-13. PubMed ID: 4952941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Realization of the cytotoxic properties of Flexner shigellae in a macrophage culture at the cellular and subcellular level].
    Nosova LS; Zhdanov EE; Trofimova MN
    Vestn Akad Med Nauk SSSR; 1976; (1):24-9. PubMed ID: 790819
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of virulence functions through glucosylation of Shigella LPS.
    West NP; Sansonetti P; Mounier J; Exley RM; Parsot C; Guadagnini S; Prévost MC; Prochnicka-Chalufour A; Delepierre M; Tanguy M; Tang CM
    Science; 2005 Feb; 307(5713):1313-7. PubMed ID: 15731456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on experimental keratoconjunctivitis shigellosa.
    Okamoto M
    Kitasato Arch Exp Med; 1980 Dec; 53(3-4):81-96. PubMed ID: 7035740
    [No Abstract]   [Full Text] [Related]  

  • 16. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials.
    Bingrui W
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):285-9. PubMed ID: 6400301
    [No Abstract]   [Full Text] [Related]  

  • 17. ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.
    FORMAL SB; LABREC EH; KENT TH; FALKOW S
    J Bacteriol; 1965 May; 89(5):1374-82. PubMed ID: 14293011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione.
    Flamant M; Aubert P; Rolli-Derkinderen M; Bourreille A; Neunlist MR; Mahé MM; Meurette G; Marteyn B; Savidge T; Galmiche JP; Sansonetti PJ; Neunlist M
    Gut; 2011 Apr; 60(4):473-84. PubMed ID: 21139062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of pathogenicity tests for Shigella spp. and enteroinvasive Escherichia coli strains.
    Cristea D; Ceciu S; Chitoiu DT; Bleotu C; Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2009; 68(1):44-9. PubMed ID: 19507627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on biochemical variants of Sh. flexneri. II. Studies on mannitol negative variants of Sh. flexneri 3a.
    Trifonova A; Pencheva P; Tekelieva R; Hashumova I
    Zentralbl Bakteriol Orig A; 1974 Mar; 226(3):349-54. PubMed ID: 4151799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.